CinCor Pharma is a clinical-stage biopharmaceutical company focused on developing innovative treatments for cardiovascular and renal diseases, particularly through its lead product candidate, CIN-107, an aldosterone synthase inhibitor
CinCor Pharma is a clinical-stage biopharmaceutical company focused on developing innovative treatments for cardiovascular and renal diseases, particularly through its lead product candidate, CIN-107, an aldosterone synthase inhibitor.
The top three firms on F4's Biotech & Life Sciences investor list.